|
시장보고서
상품코드
1372517
어류 백신 시장 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 리포트 대상 범위 : 백신 유형별, 용도별, 투여 경로별, 생물 종류별, 지역별Fish Vaccine Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Vaccine Type, Application, Route of Administration, Species, and Geography |
||||||
어류 백신 시장 규모는 2022년에 3억 5,500만 달러로 평가되며 2030년에는 6억 1,700만 달러에 달할 것으로 예측되며, 2022-2030년의 CAGR은 7.1%를 기록할 것으로 추정됩니다. 어류 백신 시장의 성장은 주로 수산양식 산업을 발전시키기 위한 정부 구상의 증가와 수산 동물 유래 식품에 대한 수요의 급증에 의해 초래됩니다.
신규 어류 백신 개척이 어류 백신 시장의 성장 기회
기생충, 바이러스, 박테리아로 인한 질병 발생은 수십년간 세계 양식 산업의 발전을 지연시켜왔습니다. 인간의 건강에 해를 끼치는 것 외에도 신흥 질병은 수산 동물에게 큰 영향을 미치고 있습니다. 기존 백신은 한계와 단점이 있으며, 키메라 멀티 에피토프 백신과 같은 새로운 첨단 백신에 대한 개발 수요가 증가하고 있습니다. 수생백신 기초 및 응용 연구 분야는 과학기술의 발전으로 새로운 길을 열어가고 있습니다. 새로운 기술, 접근법, 전략을 통해 더 높은 품질과 효율을 가진 새로운 수생 백신을 개발하기 위한 노력이 계속되고 있습니다.
이용 가능한 생물정보학 툴와 면역단백질학 및 유전체학에 대한 최신 지식을 통해 연구자들은 면역세포가 인식할 수 있는 잠재적인 표적 에피토프를 식별할 수 있습니다. 또한 전장 유전체 염기서열 분석과 같은 기술의 비용이 지속적으로 감소함에 따라 종 특이적 백신 개발의 길이 열리고 있습니다. 2021년 인도에서는 중앙기수양식연구소(ICAR)가 바이러스성 신경괴사증(VNN)에 대한 재조합 백신을 출시하는 등 새로운 백신 개발에 대한 투자가 활발해질 가능성이 높습니다.
이렇게 투여 과정을 강화한 효과적인 점막 백신의 개발은 새로운 백신 개발을 가속화하고, 지중해 국가의 양식 사업을 촉진하고, 어류 백신 접종 과정을 정기화할 것으로 예상됩니다. 따라서 새로운 어류 백신의 개발은 시장 성장을 위한 큰 기회를 창출할 가능성이 높습니다.
백신 유형별 인사이트
어류 백신 시장은 백신 유형에 따라 불활성화 백신, 생백신, 아단위 백신, 재조합 벡터 백신, 기타로 구분됩니다. 비활성화 백신 부문은 2022년 어류 백신 시장에서 가장 큰 점유율을 차지했습니다. 그러나 재조합 벡터 백신 부문은 2022-2030년 8.6%의 가장 높은 CAGR을 기록할 것으로 예상됩니다.
용도별 인사이트
어류 백신 시장은 용도별로 세균성, 바이러스성, 기생충성으로 구분됩니다. 세균성 부문은 2022년에 가장 큰 시장 점유율을 차지할 것으로 예상되며, 이 부문은 2022-2030년 동안 가장 높은 CAGR 7.4%를 나타낼 것으로 예상됩니다.
투여 경로별 인사이트
어류 백신 시장은 투여 경로에 따라 주사, 침지, 경구로 구분되며, 주사 부문이 2022년 어류 백신 시장 점유율에서 가장 큰 비중을 차지할 것으로 예상됩니다. 그러나 침지 부문은 2022-2030년 7.6%의 가장 높은 CAGR을 기록할 것으로 예상됩니다.
생물 종별 인사이트
어류 백신 시장은 연어, 송어, 틸라피아, 기타로 구분됩니다. 연어 부문은 2022년 가장 큰 시장 점유율을 차지했으며, 기타 부문은 2022-2030년 7.8%의 CAGR을 나타낼 것으로 예상됩니다.
Cole Instruments Inc, Vision Medical Inc, Bernstein Medical PC, Curallux LLC, HairMax Inc, NovaGenix LLC, Apira Science Inc, Theradome Inc, Robotics Restoration Inc, LaserCap Co 등이 세계의 어류 백신 시장에서 활동하는 주요 기업입니다.
세계의 어류 백신 시장을 아래와 같이 구분 :
어류 백신 시장은 백신 유형, 용도, 투여 경로, 생물종에 기반해 분할됩니다. 백신 유형에 기반해, 어류 백신 시장은 불활화 백신, 생백신, 서브유닛 백신, 재조합 벡터 백신, 기타로 구분됩니다. 용도에 기반해, 어류 백신 시장은 세균성, 바이러스 성, 기생충성으로 구분됩니다. 투여 경로에 기반해, 어류 백신 시장은 주사, 침지, 경구로 분류됩니다. 생물종에 기반해, 어류 백신 시장은 연어, 매스, 틸라피아, 기타로 구분됩니다. 지역별로는 어류 백신 시장은 북미(미국, 캐나다, 멕시코), 유럽(영국, 독일, 프랑스, 이탈리아, 스페인, 기타 유럽 지역), 아시아태평양(중국, 일본, 인도, 한국 , 호주, 기타 아시아태평양), 중동 및 아프리카(아랍에미리트, 사우디아라비아, 한국 , 호주, 기타 중동 및 아프리카), 남미(브라질, 아르헨티나, 기타 중동 및 아프리카)로 구분됩니다.
어류 백신 시장 보고서 작성시 참고한 주요 1차 및 2차 정보에는 OECD/FAO, 미국 농무부(USDA), 세계은행, 미국 해양대기청, 캐나다 수산해양부(DFO), 영국 상공부, 호주 국립수산개발청(NFDB), 호주 어업 및 임업부 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
- 어류 백신 시장, 지역별
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 어류 백신 시장 구도
- 서론
- PEST 분석
- 세계의 PEST 분석
제5장 어류 백신 시장 - 주요 산업 역학
- 시장 촉진요인
- 수산양식 산업 발전에 대한 정부 구상
- 수산 동물 유래 식품에 대한 수요 급증
- 시장 억제요인
- 백신 인가를 위한 엄격한 규제
- 시장 기회
- 신규 어류 백신의 개발
- 향후 동향
- 어류 백신의 기술적 진보
- 영향 분석
제6장 어류 백신 세계 시장 분석
- 어류 백신 시장 매출(US$Th), 2022-2030년
제7장 세계의 어류용 백신 시장 - 2030년까지의 매출과 예측 : 백신 유형별
- 서론
- 어류 백신 시장 2022년 및 2030년 백신 유형별 판매고 점유율(%)
- 불활화 백신
- 생백신
- 서브유닛 백신
- 재조합 벡터 백신
- 기타
제8장 세계의 어류용 백신 시장 - 2030년까지의 매출과 예측 : 용도별
- 서론
- 어류 백신 시장 2022년 및 2030년의 용도별 판매고 점유율(%)
- 세균성
- 바이러스
- 기생충
제9장 세계의 어류용 백신 시장 - 2030년까지의 매출과 예측 : 투여 경로별
- 서론
- 어류 백신 시장 2022년 및 2030년의 투여 경로별 판매고 점유율(%)
- 주사
- 침지
- 경구
제10장 어류 백신 세계 시장 : 2030년까지의 매출과 예측 : 생물 종류별
- 서론
- 어류 백신 시장 2022년 및 2030년 생물 종류별 판매고 점유율(%)
- 연어
- 송어
- 틸라피아
- 기타
제11장 어류 백신 시장 - 지역별 분석
- 북미
- 멕시코
- 유럽
- 기타 유럽
- 아시아태평양
- 기타 아시아태평양
- 중동 및 아프리카
- 기타 중동 및 아프리카
- 중남미
- 기타 중남미
제12장 어류 백신 시장 - 업계 상황
- 서론
- 어류 백신 시장의 성장 전략
- 무기적 성장 전략
- 개요
- 유기적 성장 전략
- 개요
제13장 기업 개요
- Zoetis Inc
- Merck & Co Inc
- HIPRA SA
- Phibro Animal Health Corp
- Vaxxinova International BV
- Kyoto Biken Laboratories Inc
- Elanco Animal Health Inc
- Nisseiken Co Ltd
- KBNP Inc
- Choong Ang Vaccine Laboratory
- Indian Immunologicals Ltd
제14장 부록
KSA 23.11.09The fish vaccine market size was valued at US$ 0.355 Bn in 2022 and is expected to reach US$ 0.617 Bn by 2030; it is estimated to record a CAGR of 7.1% from 2022 to 2030. The fish vaccine market growth is primarily driven by the increasing government initiatives to develop aquaculture industry and surging demand for aquatic animal-derived food products
Development of Novel Fish Vaccine Opportunity for Growth of Fish Vaccine Market
Emergence of disease outbreak caused by parasites, viruses, and bacteria have slowed down the evolution of the global aquaculture industry for several decades. Aside from being harmful to human health, emerging diseases have a significant impact on aquatic animals. Traditional vaccines have limitations and drawbacks, which bolsters the demand for the development of novel advanced vaccines such as chimeric multiepitope vaccines. Newer avenues in the basic and applied research fields of aquatic vaccines have been opened up by scientific and technological advancements. An effort has been made to create novel aquatic vaccines with higher quality and efficiency using new technologies, approaches, and strategies.
Using the available bioinformatics tools and current knowledge of immunoproteomics and genomics, researchers can identify potential targeted epitopes that immune cells can recognize. Further, as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. This is likely to boost investments in developing new vaccines. In 2021, the Central Institute of Brackishwater Aquaculture (ICAR) launched a recombinant vaccine against viral nervous necrosis (VNN) in India.
Thus, the development of an effective mucosal vaccine with strengthening the administration process is expected to accelerate the novel vaccine development, which would boost the aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. Hence, development of novel fish vaccines is likely creating significant opportunity for market growth
Vaccine Type-Based Insights
The fish vaccine market, by vaccine type, is segmented into inactivated vaccines, live vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest share in fish vaccine market in 2022. However, recombinant vector vaccine segment is anticipated to register the highest CAGR of 8.6% during 2022-2030.
Application-Based Insights
The fish vaccine market, by application, is segmented into bacterial, viral, and parasitic. The bacterial segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR of 7.4% during 2022-2030.
Route of Administration -Based Insights
The fish vaccine market, by route of administration, is segmented into injected, immersion, and oral. The injected segment held the largest share in fish vaccine market share in 2022. However, immersion segment is anticipated to register a highest CAGR of 7.6% during 2022-2030.
Species-Based Insights
The fish vaccine market, by species, is segment into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022 whereas, others segment is anticipated to register the highest CAGR of 7.8% during 2022-2030
Cole Instruments Inc, Vision Medical Inc, Bernstein Medical PC, Curallux LLC, HairMax Inc, NovaGenix LLC, Apira Science Inc, Theradome Inc, Robotics Restoration Inc, and LaserCap Co are among the key players operating in the global fish vaccine market.
The report segments the global fish vaccine market as follows:
The fish vaccine market is divided on the basis of vaccine type, application, route of administration, and species. Based on vaccine type, the fish vaccine market is segmented into inactivated vaccines, live vaccines, subunit vaccines, recombinant vector vaccine, and others. Based on the application, the fish vaccine market is segmented into bacterial, viral, and parasitic. Based on the route of administration, the fish vaccine market is classified into injected, immersion, and oral. Based on species, the fish vaccine market is segmented into salmon, trout, tilapia, and others. Based on geography, the fish vaccine market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
A few of the major primary and secondary sources referred to while preparing the report on the fish vaccine market are the OECD/FAO, US Department of Agriculture (USDA), World Bank, the National Oceanic and Atmospheric Administration, Fisheries and Oceans Canada (DFO), Department of Business and Trade (UK), National Fisheries Development Board (NFDB), Department of Agriculture, Fisheries and Forestry of Australia
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the fish vaccine market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the fish vaccine market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the fish vaccine market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Fish Vaccine Market, by Geography
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Fish Vaccine Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 Global PEST Analysis
5. Fish Vaccine Market - Key Industry Dynamics
- 5.1 Market Drivers:
- 5.1.1 Government Initiatives to Develop Aquaculture Industry
- 5.1.2 Surging Demand for Aquatic Animal-Derived Food Products
- 5.2 Market Restraints
- 5.2.1 Stringent Regulations for Approval of Vaccine
- 5.3 Market Opportunities
- 5.3.1 Development of Novel Fish Vaccine
- 5.4 Future Trends
- 5.4.1 Technological Advancements in Fish Vaccine
- 5.5 Impact Analysis:
6. Fish Vaccine Market - Global Market Analysis
- 6.1 Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
7. Global Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type
- 7.1 Overview
- 7.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
- 7.3 Inactivated Vaccines
- 7.3.1 Overview
- 7.3.2 Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 7.4 Live Vaccines
- 7.4.1 Overview
- 7.4.2 Live Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 7.5 Subunit Vaccines
- 7.5.1 Overview
- 7.5.2 Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 7.6 Recombinant Vector Vaccine
- 7.6.1 Overview
- 7.6.2 Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
8. Global Fish Vaccine Market - Revenue and Forecast to 2030 - by Application
- 8.1 Overview
- 8.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
- 8.3 Bacterial
- 8.3.1 Overview
- 8.3.2 Bacterial: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 8.4 Viral
- 8.4.1 Overview
- 8.4.2 Viral: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 8.5 Parasitic
- 8.5.1 Overview
- 8.5.2 Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9. Global Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration
- 9.1 Overview
- 9.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
- 9.3 Injected
- 9.3.1 Overview
- 9.3.2 Injected: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 9.4 Immersion
- 9.4.1 Overview
- 9.4.2 Immersion: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 9.5 Oral
- 9.5.1 Overview
- 9.5.2 Oral: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
10. Global Fish Vaccine Market - Revenue and Forecast to 2030 - by Species
- 10.1 Overview
- 10.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
- 10.3 Salmon
- 10.3.1 Overview
- 10.3.2 Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 10.4 Trout
- 10.4.1 Overview
- 10.4.2 Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 10.5 Tilapia
- 10.5.1 Overview
- 10.5.2 Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
11. Fish Vaccine Market - Geographical Analysis
- 11.1 North America Fish Vaccine Market, Revenue and Forecast To 2030
- 11.1.1 Overview
- 11.1.2 North America Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.1.3 North America: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.1.4 North America: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.1.5 North America: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.1.6 North America: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.1.7 North America Fish Vaccine Market, by Country
- 11.1.7.1 US
- 11.1.7.1.1 Overview
- 11.1.7.1.2 US Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.1.7.1.3 US: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.1.7.1.4 US: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.1.7.1.5 US: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.1.7.1.6 US: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.1.7.2 Canada
- 11.1.7.2.1 Overview
- 11.1.7.2.2 Canada Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.1.7.2.3 Canada: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.1.7.2.4 Canada: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.1.7.2.5 Canada: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.1.7.2.6 Canada: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.1.7.3 Mexico
- 11.1.7.3.1 Overview
- 11.1.7.3.2 Mexico Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.1.7.3.3 Mexico: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.1.7.3.4 Mexico: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.1.7.3.5 Mexico: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.1.7.3.6 Mexico: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.1.7.1 US
- 11.2 Europe Fish Vaccine Market, Revenue and Forecast to 2030
- 11.2.1 Overview
- 11.2.2 Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.2.3 Europe: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.2.4 Europe: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.2.5 Europe: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.2.6 Europe: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.2.7 Europe Fish Vaccine Market, by Country
- 11.2.7.1 UK
- 11.2.7.1.1 Overview
- 11.2.7.1.2 UK Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.2.7.1.3 UK: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.2.7.1.4 UK: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.2.7.1.5 UK: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.2.7.1.6 UK: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.2.7.2 Germany
- 11.2.7.2.1 Overview
- 11.2.7.2.2 Germany Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.2.7.2.3 Germany: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.2.7.2.4 Germany: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.2.7.2.5 Germany: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.2.7.2.6 Germany: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.2.7.3 France
- 11.2.7.3.1 Overview
- 11.2.7.3.2 France Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.2.7.3.3 France: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.2.7.3.4 France: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.2.7.3.5 France: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.2.7.3.6 France: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.2.7.4 Italy
- 11.2.7.4.1 Overview
- 11.2.7.4.2 Italy Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.2.7.4.3 Italy: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.2.7.4.4 Italy: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.2.7.4.5 Italy: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.2.7.4.6 Italy: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.2.7.5 Spain
- 11.2.7.5.1 Overview
- 11.2.7.5.2 Spain Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.2.7.5.3 Spain: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.2.7.5.4 Spain: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.2.7.5.5 Spain: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.2.7.5.6 Spain: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.2.7.6 Rest of Europe
- 11.2.7.6.1 Overview
- 11.2.7.6.2 Rest of Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.2.7.6.3 Rest of Europe: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.2.7.6.4 Rest of Europe: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.2.7.6.5 Rest of Europe: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.2.7.6.6 Rest of Europe: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.2.7.1 UK
- 11.3 Asia Pacific Fish Vaccine Market, Revenue and Forecast to 2030
- 11.3.1 Overview
- 11.3.2 Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.3.3 Asia Pacific: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.3.4 Asia Pacific: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.3.5 Asia Pacific: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.3.6 Asia Pacific: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.3.7 Asia Pacific Fish Vaccine Market, by Country
- 11.3.7.1 China
- 11.3.7.1.1 Overview
- 11.3.7.1.2 China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.3.7.1.3 China: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.3.7.1.4 China: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.3.7.1.5 China: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.3.7.1.6 China: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.3.7.2 Japan
- 11.3.7.2.1 Overview
- 11.3.7.2.2 Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.3.7.2.3 Japan: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.3.7.2.4 Japan: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.3.7.2.5 Japan: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.3.7.2.6 Japan: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.3.7.3 India
- 11.3.7.3.1 Overview
- 11.3.7.3.2 India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.3.7.3.3 India: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.3.7.3.4 India: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.3.7.3.5 India: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.3.7.3.6 India: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.3.7.4 Australia
- 11.3.7.4.1 Overview
- 11.3.7.4.2 Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.3.7.4.3 Australia: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.3.7.4.4 Australia: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.3.7.4.5 Australia: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.3.7.4.6 Australia: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.3.7.5 South Korea
- 11.3.7.5.1 Overview
- 11.3.7.5.2 South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.3.7.5.3 South Korea: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.3.7.5.4 South Korea: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.3.7.5.5 South Korea: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.3.7.5.6 South Korea: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.3.7.6 Rest of Asia Pacific
- 11.3.7.6.1 Overview
- 11.3.7.6.2 Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.3.7.6.3 Rest of Asia Pacific: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.3.7.6.4 Rest of Asia Pacific: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.3.7.6.5 Rest of Asia Pacific: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.3.7.6.6 Rest of Asia Pacific: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.3.7.1 China
- 11.4 Middle East & Africa Fish Vaccine Market, Revenue and Forecast to 2030
- 11.4.1 Overview
- 11.4.2 Middle East & Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.4.3 Middle East & Africa: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.4.4 Middle East & Africa: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.4.5 Middle East & Africa: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.4.6 Middle East & Africa: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.4.6.1 Middle East & Africa Fish Vaccine Market, by Country
- 11.4.6.2 Saudi Arabia
- 11.4.6.2.1 Overview
- 11.4.6.2.2 Saudi Arabia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.4.6.2.3 Saudi Arabia: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.4.6.2.4 Saudi Arabia: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.4.6.2.5 Saudi Arabia: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.4.6.2.6 Saudi Arabia: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.4.6.3 South Africa
- 11.4.6.3.1 Overview
- 11.4.6.3.2 South Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.4.6.3.3 South Africa: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.4.6.3.4 South Africa: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.4.6.3.5 South Africa: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.4.6.3.6 South Africa: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.4.6.4 UAE
- 11.4.6.4.1 Overview
- 11.4.6.4.2 UAE Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.4.6.4.3 UAE: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.4.6.4.4 UAE: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.4.6.4.5 UAE: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.4.6.4.6 UAE: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.4.6.5 Rest of Middle East Africa
- 11.4.6.5.1 Overview
- 11.4.6.5.2 Rest of Middle East Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.4.6.5.3 Rest of Middle East Africa: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.4.6.5.4 Rest of Middle East Africa: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.4.6.5.5 Rest of Middle East Africa: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.4.6.5.6 Rest of Middle East Africa: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.5 South & Central America Fish Vaccine Market, Revenue and Forecast to 2030
- 11.5.1 Overview
- 11.5.2 South & Central America Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.5.3 South & Central America: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.5.4 South & Central America: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.5.5 South & Central America: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.5.6 South & Central America: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.5.7 South & Central America Fish Vaccine Market, by Country
- 11.5.7.1 Brazil
- 11.5.7.1.1 Overview
- 11.5.7.1.2 Brazil Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.5.7.1.3 Brazil: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.5.7.1.4 Brazil: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.5.7.1.5 Brazil: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.5.7.1.6 Brazil: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.5.7.2 Argentina
- 11.5.7.2.1 Overview
- 11.5.7.2.2 Argentina Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.5.7.2.3 Argentina: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.5.7.2.4 Argentina: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.5.7.2.5 Argentina: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.5.7.2.6 Argentina: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.5.7.3 Rest of South & Central America
- 11.5.7.3.1 Overview
- 11.5.7.3.2 Rest of South & Central America Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 11.5.7.3.3 Rest of South & Central America: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 11.5.7.3.4 Rest of South & Central America: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 11.5.7.3.5 Rest of South & Central America: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 11.5.7.3.6 Rest of South & Central America: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 11.5.7.1 Brazil
12. Fish Vaccine Market - Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies in Fish Vaccine Market
- 12.3 Inorganic Growth Strategies
- 12.3.1 Overview
- 12.4 Organic Growth Strategies
- 12.4.1 Overview
13. Company Profiles
- 13.1 Zoetis Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Merck & Co Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 HIPRA SA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Phibro Animal Health Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Vaxxinova International BV
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Kyoto Biken Laboratories Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Elanco Animal Health Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 Nisseiken Co Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 KBNP Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 Choong Ang Vaccine Laboratory
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
- 13.11 Indian Immunologicals Ltd
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
14. Appendix
- 14.1 About Us
- 14.2 Glossary of Terms
